Thyrofit – 25 (Synthroid)0.25 Mcg – 300 tablets

USD $15.71

Each Thyrofit 25 contains 25 mcg Thyroxine Sodium 300 tablets and It is used to add thyroid hormone to the body and off label use for fitness.

ATC Classification: H03AA01
Active Ingrediant: Thyroxine Sodium
Generic Name: Thyrofit – 25
Manufacturer: Eris Life
Strength: 0.25 Mcg
Dosage Type: Tabs
Packaging Type: Foil in Box
Contains: 30 Tabs

Examples of Packages sent

What is this drug used for?

– It is used to add thyroid hormone to the body.

– It is used to manage thyroid cancer.

– It may be given to you for other reasons. Talk with the doctor.

Frequently reported side effects of this drug

– Hair loss

Other side effects of this drug: Talk with your doctor right away if you have any of these signs of:

– Chest pain

– Fast heartbeat

– Abnormal heartbeat

– Headache

– Dizziness

– Passing out

– Vision changes

– Shortness of breath

– Loss of strength and energy

– Lack of appetite

– Increased appetite

– Excessive weight gain or loss

– Swelling of arms or legs

– Diarrhea

– Abdominal cramps

– Vomiting

– Irritability

– Anxiety

– Emotional instability

– Tremors

– Trouble sleeping

– Temperature sensitivity

– Sweating a lot

– Muscle cramps

– Muscle weakness

– Flushing

– Bone pain

– Menstrual irregularities

– Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.

Note:?This is not a comprehensive list of all side effects. Talk to your doctor if you have questions.



(lee voe thye ROKS een)


Medication Safety Issues

Sound-alike/look-alike issues:

Levothyroxine may be confused with lamoTRIgine, Lanoxin, levoFLOXacin, liothyronine

Levoxyl may be confused with Lanoxin, Levaquin, Luvox

Synthroid may be confused with Symmetrel

Administration issues:

Significant differences exist between oral and IV dosing. Use caution when converting from one route of administration to another.

Other safety concerns:

To avoid errors due to misinterpretation of a decimal point, always express dosage in mcg (not?mg).


Generic Availability: US

May be product dependent


Storage and Stability

Capsules and tablets: Store at 25?C (77?F); excursions are permitted between 15?C and 30?C (59?F and 86?F). Protect from heat, light, and moisture.

Oral solution (Tirosint): Store in original container (closed aluminum pouch) at 25?C (77?F); excursions are permitted between 15?C and 30?C (59?F and 86?F). Keep ampules in pouch until ready to use; after opening the pouch, all ampules in the pouch should be used within 15 days.

Injection: Store at 20?C to 25?C (68?F to 77?F). Protect from light.

Additional stability data:

Stability in polypropylene syringes (100 mcg/mL in NS) at 5?C ? 1?C is 7 days (Gupta 2000).

Stability in latex-free, PVC minibags protected from light and stored at 15?C to 30?C (59?F to 86?F) was 12 hours for a 2 mcg/mL concentration or 18 hours for a 0.4 mcg/mL concentration in NS. May be exposed to light; however, stability time is significantly reduced, especially for the 2 mcg/mL concentration (Strong 2010).


Adverse Reactions

Adverse reactions are primarily those of hyperthyroidism due to therapeutic overdosage.

Cardiovascular: Angina pectoris, cardiac arrhythmia, cardiac failure, flushing, increased blood pressure, increased pulse, myocardial infarction, palpitations, tachycardia

Central nervous system: Anxiety, emotional lability, fatigue, headache, heat intolerance, hyperactivity, insomnia, irritability, myasthenia, nervousness, pseudotumor cerebri (children)

Dermatologic: Alopecia, diaphoresis, skin rash

Endocrine & metabolic: Goiter (exophthalmic; IV), menstrual disease, weight loss

Gastrointestinal: Abdominal cramps, diarrhea, increased appetite, vomiting

Genitourinary: Reduced fertility

Hepatic: Increased liver enzymes

Neuromuscular & skeletal: Decreased bone mineral density, muscle spasm, slipped capital femoral epiphysis (children), tremor

Respiratory: Dyspnea

Miscellaneous: Fever

Rare but important or life-threatening: Dysgeusia (Syed 2016), seizure

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,


Dosage Type

Packaging Type


Eris Life


There are no reviews yet.

Be the first to review “Thyrofit – 25 (Synthroid)0.25 Mcg – 300 tablets”

Your email address will not be published. Required fields are marked *